Journal
IMMUNOLOGY AND CELL BIOLOGY
Volume 87, Issue 4, Pages 279-286Publisher
WILEY
DOI: 10.1038/icb.2009.14
Keywords
tuberculosis; bacterial; vaccination; BCG; latency
Categories
Ask authors/readers for more resources
Vaccines against intracellular pathogens such as Mycobacterium tuberculosis need to induce strong cellular immune responses. Antigen discovery programs have exploited this and used proteome studies and T-cell recognition in PPD-positive individuals to select proteins and after testing for protective efficacy in animals the most promising proteins have been put together in fusion molecules. Three such fusion proteins are currently in clinical trials, the two most advanced have already passed phase I trials and are entering phase II. Immunology and Cell Biology ( 2009) 87, 279-286; doi:10.1038/icb.2009.14; published online 7 April 2009
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available